2023-03-01 2024-02-29 false No description of principal activity Capium Accounts Production 1.1 10642021 bus:FullAccounts 2023-03-01 2024-02-29 10642021 bus:FRS102 2023-03-01 2024-02-29 10642021 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 10642021 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 10642021 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 10642021 2023-03-01 2024-02-29 10642021 2024-02-29 10642021 bus:RegisteredOffice 2023-03-01 2024-02-29 10642021 core:WithinOneYear 2024-02-29 10642021 core:AfterOneYear 2024-02-29 10642021 bus:Director1 2023-03-01 2024-02-29 10642021 bus:Director1 2024-02-29 10642021 bus:Director1 2022-03-01 2023-02-28 10642021 bus:Director2 2023-03-01 2024-02-29 10642021 bus:Director2 2024-02-29 10642021 bus:Director2 2022-03-01 2023-02-28 10642021 bus:Director3 2023-03-01 2024-02-29 10642021 bus:Director3 2024-02-29 10642021 bus:Director3 2022-03-01 2023-02-28 10642021 2022-03-01 10642021 bus:LeadAgentIfApplicable 2023-03-01 2024-02-29 10642021 2022-03-01 2023-02-28 10642021 2023-02-28 10642021 core:WithinOneYear 2023-02-28 10642021 core:AfterOneYear 2023-02-28 10642021 bus:EntityAccountantsOrAuditors 2022-03-01 2023-02-28 10642021 core:PlantMachinery 2023-03-01 2024-02-29 10642021 core:PlantMachinery 2024-02-29 10642021 core:PlantMachinery 2023-02-28 10642021 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-02-29 10642021 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-02-28 10642021 core:CostValuation core:Non-currentFinancialInstruments 2024-02-29 10642021 core:CostValuation core:Non-currentFinancialInstruments 2023-02-28 10642021 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-02-29 10642021 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-29 10642021 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-29 10642021 core:Non-currentFinancialInstruments 2024-02-29 10642021 core:Non-currentFinancialInstruments 2023-02-28 10642021 core:ShareCapital 2024-02-29 10642021 core:ShareCapital 2023-02-28 10642021 core:RetainedEarningsAccumulatedLosses 2024-02-29 10642021 core:RetainedEarningsAccumulatedLosses 2023-02-28 10642021 dpl:Item1 2023-03-01 10642021 dpl:Item1 2024-02-29 10642021 dpl:Item1 2022-03-01 10642021 dpl:Item1 2023-02-28 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10642021
England and Wales

 

 

 

ROBUST TESTING SOLUTIONS LTD


Unaudited Financial Statements
 


Period of accounts

Start date: 01 March 2023

End date: 29 February 2024
Directors Mr S A Bartholomew
Mr T Gregory
Mr S J Hayden
Registered Number 10642021
Registered Office 16 Wicket Avenue
Rainham
Kent
ME8 7EZ
1
Director's report and financial statements
The directors present his/her/their annual report and the financial statements for the year ended 29 February 2024.
Directors
The directors who served the company throughout the year were as follows:
Mr S A Bartholomew
Mr T Gregory
Mr S J Hayden

This report was approved by the board and signed on its behalf by:


----------------------------------
Mr T Gregory
Director

Date approved: 11 November 2024
2
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 4   2,366 
Investments 5 48,000    48,000 
48,000    50,366 
Current assets      
Debtors 6 32,626    43,157 
Cash at bank and in hand 148,886    153,805 
181,512    196,962 
Creditors: amount falling due within one year 7 (40,692)   (55,906)
Net current assets 140,820    141,056 
 
Total assets less current liabilities 188,820    191,422 
Net assets 188,820    191,422 
 

Capital and reserves
     
Called up share capital 90    90 
Profit and loss account 188,730    191,332 
Shareholders' funds 188,820    191,422 
 


For the year ended 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 11 November 2024 and were signed on its behalf by:


-------------------------------
Mr T Gregory
Director
3
General Information
Robust Testing Solutions Ltd is a private company, limited by shares, registered in England and Wales, registration number 10642021, registration address 16 Wicket Avenue, Rainham, Kent, ME8 7EZ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared on the going concern basis and under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements
contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods
supplied and services rendered, net of discounts and Value Added Tax. 

Revenue from the sale of goods is recognised when the significant risks and rewards of
ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised
in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. 

Current tax is recognised on taxable profit for the current and past periods. Current tax is
measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. 

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved
tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any
accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. 

An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other
comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss. 
Plant and Machinery 20% Straight Line
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Investments in associates

Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses.

Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted.

Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.

Investments in joint ventures

Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses.

Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted.

Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.

For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to
the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost. 

Where investments in non-convertible preference shares and non-puttable ordinary shares or
preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. 

Other financial instruments, including derivatives, are initially recognised at fair value, unless
payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Other financial instruments are subsequently measured at fair value, with any changes
recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship. 

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence
of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. 

For all equity instruments regardless of significance, and other financial assets that are
individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. 

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the
reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
2.

Employee numbers


Average number of employees during the year was 4 (2023 : 4).
3.

Investments



The company's investments at the Balance Sheet date in the share capital of companies include the following:

Air Leakage testing Limited
Registered office: 7 Lawson Way, Aylesbury, Bucks, HP18 0UW
Nature of business: Air testing services for the construction industry

Class of shares: Ordinary
% holding: 100.00

Subsidiary undertakings   Capital and reserves 2024
£
  Capital and reserves 2023
£
  Profit/(Loss) 2024
£
  Profit/(Loss) 2023
£
Air Leakage Testing Ltd 280,085  280,682  264,403  254,509 


4.

Tangible fixed assets

Cost or valuation Plant and Machinery   Total
  £   £
At 01 March 2023 28,259    28,259 
Additions  
Disposals  
At 29 February 2024 28,259    28,259 
Depreciation
At 01 March 2023 25,893    25,893 
Charge for year 2,366    2,366 
On disposals  
At 29 February 2024 28,259    28,259 
Net book values
Closing balance as at 29 February 2024  
Opening balance as at 01 March 2023 2,366    2,366 


5.

Investments

Cost Investments in group undertakings   Total
  £   £
At 01 March 2023 48,000    48,000 
Additions  
Transfer to/from tangible fixed assets  
Disposals  
At 29 February 2024 48,000    48,000 

6.

Debtors: amounts falling due within one year

2024
£
  2023
£
Trade Debtors 30,420    40,540 
Other Debtors  
PAYE & Social Security 2,206    2,617 
32,626    43,157 

7.

Creditors: amount falling due within one year

2024
£
  2023
£
Trade Creditors 176    176 
Amounts Owed to Group Undertakings 6,592    6,592 
Corporation Tax 14,772    25,005 
Accrued Expenses 1,400    1,400 
Other Creditors 320    800 
Directors' Current Accounts 1,872    936 
VAT 15,560    20,997 
40,692    55,906 

4